Matches in SemOpenAlex for { <https://semopenalex.org/work/W2561720150> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W2561720150 endingPage "63" @default.
- W2561720150 startingPage "57" @default.
- W2561720150 abstract "Aim. To study clinical symptoms dynamics, functional condition, the quality of life, and cardiac structure and function in patients having chronic heart failure with preserved ejection fraction (CHFPEF) after Spironolactone (S) and its combination with Trimetazidine (S+T) therapy.Methods. 90 patients (aged from 60-74 years) suffering from hypertension with CHFPEF were examined using echocardiography, 6-minute walk test (SMWT), and the Minnesota living with heart failure questionnaire (MLHF) before, 6 and 12 months later after the standard therapy (K), standard with S use, and standard with S+T use.Results. On the clinical symptoms positive dynamics background, the distance of SMWT significantly increased on 26±9 m in К, 36±9 m in S, and 55±8 m in S+T; according to the MLHF, the number of points decreased: on 9,9±2,4, 17,1±2,6 і 12,9±2,3, respectively. A statistically significant decrease in left ventricular mass (LV) was on 10,4±4,4 g in К, 22,1±7,9 g in S, and 28,6±7,7g in S+T, but only in S and in S+T it accompanied by left atrium decrease – on 9,3±2,4 ml and 8,8±2,3 ml (p<0,05), respectively. The use of S and S+T led to the more expressed E/E reduction – on 2,3±0,8 cu and 2,8±0,5 cu (all р <0,05), respectively, comparing to K – on 1,2±0,4 cu (p>0,05). Systolic blood pressure (BP) in the pulmonary artery significantly decreased only in S and S+T. More distinct dynamics of echocardiographic parameters in case of S and S+T partly can be associated with more significant decrease in systolic and diastolic BP.Conclusion. Adding Spironolactone and its combination with Trimetazidine to the standard therapy of CHFPEF patients leads to the more significant functional condition positive dynamics, the quality of life, more expressed LV hypertrophy regression, system BP and BP in the pulmonary artery decrease, the improvement of LV diastolic functon" @default.
- W2561720150 created "2017-01-06" @default.
- W2561720150 creator A5004837582 @default.
- W2561720150 creator A5044782586 @default.
- W2561720150 date "2016-12-28" @default.
- W2561720150 modified "2023-09-25" @default.
- W2561720150 title "The analysis of the influence of spironolactone and its combination with trimetazidine treatment on clinical symptoms, and cardiac structure and function parameters in chronic heart failure with preserved ejection fraction patients" @default.
- W2561720150 doi "https://doi.org/10.15587/2519-4798.2016.87853" @default.
- W2561720150 hasPublicationYear "2016" @default.
- W2561720150 type Work @default.
- W2561720150 sameAs 2561720150 @default.
- W2561720150 citedByCount "0" @default.
- W2561720150 crossrefType "journal-article" @default.
- W2561720150 hasAuthorship W2561720150A5004837582 @default.
- W2561720150 hasAuthorship W2561720150A5044782586 @default.
- W2561720150 hasBestOaLocation W25617201501 @default.
- W2561720150 hasConcept C111566952 @default.
- W2561720150 hasConcept C126322002 @default.
- W2561720150 hasConcept C159110408 @default.
- W2561720150 hasConcept C164705383 @default.
- W2561720150 hasConcept C2776379505 @default.
- W2561720150 hasConcept C2777927741 @default.
- W2561720150 hasConcept C2778198053 @default.
- W2561720150 hasConcept C2779951463 @default.
- W2561720150 hasConcept C71924100 @default.
- W2561720150 hasConcept C78085059 @default.
- W2561720150 hasConceptScore W2561720150C111566952 @default.
- W2561720150 hasConceptScore W2561720150C126322002 @default.
- W2561720150 hasConceptScore W2561720150C159110408 @default.
- W2561720150 hasConceptScore W2561720150C164705383 @default.
- W2561720150 hasConceptScore W2561720150C2776379505 @default.
- W2561720150 hasConceptScore W2561720150C2777927741 @default.
- W2561720150 hasConceptScore W2561720150C2778198053 @default.
- W2561720150 hasConceptScore W2561720150C2779951463 @default.
- W2561720150 hasConceptScore W2561720150C71924100 @default.
- W2561720150 hasConceptScore W2561720150C78085059 @default.
- W2561720150 hasIssue "12 (8)" @default.
- W2561720150 hasLocation W25617201501 @default.
- W2561720150 hasLocation W25617201502 @default.
- W2561720150 hasOpenAccess W2561720150 @default.
- W2561720150 hasPrimaryLocation W25617201501 @default.
- W2561720150 hasRelatedWork W1883738259 @default.
- W2561720150 hasRelatedWork W2360666536 @default.
- W2561720150 hasRelatedWork W2363366439 @default.
- W2561720150 hasRelatedWork W2371199711 @default.
- W2561720150 hasRelatedWork W2376458419 @default.
- W2561720150 hasRelatedWork W2385142442 @default.
- W2561720150 hasRelatedWork W2392813375 @default.
- W2561720150 hasRelatedWork W2915561147 @default.
- W2561720150 hasRelatedWork W2978597367 @default.
- W2561720150 hasRelatedWork W3030122643 @default.
- W2561720150 hasVolume "0" @default.
- W2561720150 isParatext "false" @default.
- W2561720150 isRetracted "false" @default.
- W2561720150 magId "2561720150" @default.
- W2561720150 workType "article" @default.